MicroRNAs in insulin resistance and obesity - Wikidata - wikimedia - TriplyDB

MicroRNAs in insulin resistance and obesity

MicroRNAs in insulin resistance and obesity

http://www.wikidata.org/entity/Q27023327

about

Molecular Pathogenesis of NASH MicroRNAs 9 and 370 Association with Biochemical Markers in T2D and CAD Complication of T2D Detection of circulating parasite-derived microRNAs in filarial infections MicroRNA-29 fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes.Current review of genetics of human obesity: from molecular mechanisms to an evolutionary perspective.The pathophysiology of hypertension in patients with obesity.A neuron-specific deletion of the microRNA-processing enzyme DICER induces severe but transient obesity in mice.MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine.Inhibition of miR-29 has a significant lipid-lowering benefit through suppression of lipogenic programs in liver.MicroRNA Expression Relating to Dietary-Induced Liver Steatosis and NASH.Integrative mRNA-microRNA analyses reveal novel interactions related to insulin sensitivity in human adipose tissue.Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver disease Obesity-associated oxidative stress: strategies finalized to improve redox state.Genetic regulation of human adipose microRNA expression and its consequences for metabolic traits Expression of miR-199a-3p in human adipocytes is regulated by free fatty acids and adipokines.miR-200a regulates Rheb-mediated amelioration of insulin resistance after duodenal-jejunal bypass.Development of Insulin Resistance through Induction of miRNA-135 in C2C12 Cells Plasma microRNA biomarker detection for mild cognitive impairment using differential correlation analysis.MicroRNAs regulate human adipocyte lipolysis: effects of miR-145 are linked to TNF-α.A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus.Role of microRNAs in the treatment of type 2 diabetes mellitus with Roux-en-Y gastric bypass.Oxidative-stress-induced epigenetic changes in chronic diabetic complications.The physiological and pathophysiological roles of adipocyte miRNAs.The potential of novel biomarkers to improve risk prediction of type 2 diabetes.Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128.Insulin resistance associated genes and miRNAs.Can metabolically healthy obesity be explained by diet, genetics, and inflammation?MicroRNAs as biomarkers and regulators of nonalcoholic fatty liver disease.MicroRNA 375 mediates palmitate-induced enteric neuronal damage and high-fat diet-induced delayed intestinal transit in mice.Role of Micro RNA-205 in Promoting Visceral Adiposity of NZ10 Mice with Polygenic Susceptibility for Type 2 Diabetes.MicroRNA-199a-3p attenuates hepatic lipogenesis by targeting Sp1.Plasma MicroRNA signature predicting weight gain among Mexican-American women.Circulating osteocyte-derived exosomes contain miRNAs which are enriched in exosomes from MLO-Y4 cells.Involvement of miR-539-5p in the inhibition of de novo lipogenesis induced by resveratrol in white adipose tissue.Analysis of circulating microRNAs that are specifically increased in hyperlipidemic and/or hyperglycemic sera.Diet-induced obesity alters immune cell infiltration and expression of inflammatory cytokine genes in mouse ovarian and peri-ovarian adipose depot tissues.Pathological Effects of Exosomes in Mediating Diabetic Cardiomyopathy.Profiling Circulating miRNAs from the Plasma of Individuals with Metabolic Syndrome.miR199a-5p inhibits hepatic insulin sensitivity via suppression of ATG14-mediated autophagy.An integrative transcriptomic approach to identify depot differences in genes and microRNAs in adipose tissues from high fat fed mice.

P2860

Q28071265-B14B3B3E-72F0-442F-850A-C32B8B4F13FB Q28547296-1DD7DA4B-5C44-44D8-BAC8-D1104B030887 Q28655587-8B33B306-0BA4-4873-89B6-5A1976C5C9FE Q34077389-7F26C359-50EB-4E4F-AF5E-25ED1FA722B0 Q34466165-ECD77E89-7A87-4A41-A366-774708912D5E Q35021492-77A651EF-9763-4A9A-9505-0977EE8CE083 Q35550558-61E04EFD-D19E-4D3D-A29C-D65F0E3A2613 Q35715931-54F0A9AA-BD5C-4B21-9A64-C34DC3786E55 Q35922081-B03C9F83-E402-4008-92EA-E80D49D4A2DE Q36329460-4735E614-3CD9-4AA3-8B8D-7B60E11833B9 Q36510627-DDA3E5EA-AD10-4B4C-A85B-D84601C1DBE0 Q36597717-747A4C7D-AC6F-499B-B07D-D4E6A6937B14 Q36913776-CA2BCCC9-2151-4F2B-A2AD-DA95E084A509 Q36975145-8467C685-01BC-4A54-BECA-9D30BB4C194F Q37082994-45B51445-28FE-4051-B444-A7E0906FBAD5 Q37151171-294A04BF-A0A2-4B93-A91C-78A6D67F1B2A Q37232019-7961F08E-1BBB-41D7-A56D-1DD7BD67EE0E Q37494206-35B119B6-52F0-4807-A947-D2538908950B Q37514310-4747D1BA-592E-4351-AD6E-1C173908D15F Q37728970-969DB2F8-ABDB-4ADF-BDA2-20630DC7766B Q37735780-E141635B-7C20-4F98-92EA-2F91D1E97B2D Q38093867-CA1FC710-DD4E-496B-AE3D-95C541A2113E Q38121902-3E966645-88F0-4E9B-AE60-9D9EA9686088 Q38146916-701EAA49-0F50-48C5-8EC6-9AF65684F62E Q38189850-5D5B31C1-AE62-4283-8F4A-CE6E0B17CE83 Q38225286-8F71240E-DB53-4AFA-87C6-CF7571C00F2D Q38270746-60681865-D3C5-49D3-98AA-972EE3734B2B Q38954546-109FEF1A-E2B3-4CD1-9205-441BD1E20C8B Q39026058-C5126067-BA67-4E33-A23D-30FC419D8269 Q40214092-AE8B8B70-00CE-46D2-8194-13C7E3AFA135 Q40227278-CE44F033-E3A8-4398-A41D-CEB15ECAF527 Q40273953-4E05AD75-7056-4249-9113-E9758E6769BD Q41785307-12E1723A-6211-44C0-9356-64335DDB89AB Q42813148-D6C5558D-F0AB-4B9B-A843-724A29017D71 Q46792665-DB370578-6379-4A9F-8E83-2ED65555FD5C Q47573448-F639142D-5EE7-4B3B-9ABD-69659F33D897 Q47763435-807AE70E-198E-4547-B6F6-4D6AD1261179 Q51071518-A3FF132C-3B89-4D43-8F17-3246A45AA02B Q51763083-BF7F1FC2-6BA8-4B97-91B3-C5E9605B0FAD Q52672958-7DC2B3FE-8EC3-455F-B60F-53CA6531ED8F

P2860

MicroRNAs in insulin resistance and obesity

http://www.wikidata.org/entity/Q27023327

description

2012 nî lūn-bûn

@nan

2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

MicroRNAs in insulin resistance and obesity

@ast

MicroRNAs in insulin resistance and obesity

@en

MicroRNAs in insulin resistance and obesity

@nl

type

label

MicroRNAs in insulin resistance and obesity

@ast

MicroRNAs in insulin resistance and obesity

@en

MicroRNAs in insulin resistance and obesity

@nl

prefLabel

MicroRNAs in insulin resistance and obesity

@ast

MicroRNAs in insulin resistance and obesity

@en

MicroRNAs in insulin resistance and obesity

@nl

P1433

Q27023327-77B7C01E-BA82-4E4E-B5B8-FF5E41C36889

P1476

Q27023327-EB77059F-5920-4440-B61A-D07D046C1D26

P2093

Q27023327-498ACEFC-4869-45E4-80AF-E2B662B8549D

Q27023327-C80B339C-8BE8-4DE7-98CF-6A3894E60E0C

P275

Q27023327-F2B54778-041A-4954-968D-187CF7E6915C

P2860

Q27023327-0044213D-52A2-412C-8B54-77A536D3B572

Q27023327-032AF23B-84CC-45E4-A23B-2982AA770ADD

Q27023327-035DF4C0-5378-476B-B63A-361DC9C2CC2B

Q27023327-056E47E7-BB73-4C2F-AC7E-2F083487D196

Q27023327-071D7A19-8E2E-4CBE-97D0-6E177CF5AFA7

Q27023327-07C89DBB-B4E3-4E5C-9716-ED3A599ED912

Q27023327-0C6F3F55-F8F8-4763-B282-27904006DDEE

Q27023327-0FFBFED3-7F0C-475F-92A3-DC665FC4EF89

Q27023327-12C0F4BD-4841-42FD-BDD0-B98A2D245F8F

Q27023327-1C3A52E6-61A8-4858-9575-B5672AF06CB7

P304

Q27023327-652E15E3-B2A2-468A-A5B0-EFFDAD439C74

P31

Q27023327-36861AE1-3167-43B0-BCA4-AD22087D1A9E

Q27023327-FE5420E9-9FC0-4406-8ADB-A468D460984C

P3181

Q27023327-E0364EA3-0834-4187-990D-8541165F01A9

P356

Q27023327-71414A92-863C-4587-8C3E-E12070B05B47

P407

Q27023327-19F5EFB5-BA18-4CB9-8FC4-E73911EB0E6D

P478

Q27023327-BD24D3AA-8248-45A9-8190-4E885726EA17

P5008

Q27023327-A7F6E878-0507-4DC6-B903-E6D56E1D8E87

P577

Q27023327-55F6939A-4FDF-469B-8AD8-F324FE67AD53

Q27023327-95422A21-5046-4CF3-A8FC-6CE066F9783D

P5875

Q27023327-FD0D554A-CC69-4611-9986-293DBF16BA28

P698

Q27023327-20FAA08D-6B07-48BA-B01A-11331C1B7069

P921

Q27023327-3C38CF0D-B785-4A89-B434-23EF2C581705

Q27023327-6F9A97DA-79FC-4967-9E57-90BC73908CCF

Q27023327-B853B1F9-09C0-42EC-A39E-40C2CBE218AB

Q27023327-DC403A0C-FDFC-49FC-BAC7-292A6A091353

Q27023327-FF9A977F-1723-4609-A43E-3EDCCB568C16

P932

Q27023327-24EEF2E1-BE2D-4BE2-9086-91CED2D83FE9

P3181

P356

P1433

Experimental Diabetes Research

P1476

MicroRNAs in insulin resistance and obesity

@en

P2093

Geraldine M. Mitchell

http://www.w3.org/2001/XMLSchema#string

Michael D. Williams

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 3.0 Unported

P2860

Serum microRNAs are promising novel biomarkers

MicroRNA expression in human omental and subcutaneous adipose tissue

Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs

miR-375 targets 3'-phosphoinositide-dependent protein kinase-1 and regulates glucose-induced biological responses in pancreatic beta-cells

Circulating microRNAs as stable blood-based markers for cancer detection.

miR-375 maintains normal pancreatic alpha- and beta-cell mass

Combinatorial microRNA target predictions

Identification of novel genes coding for small expressed RNAs

MicroRNAs: genomics, biogenesis, mechanism, and function

The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans

P304

484696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

969272

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2012/484696

http://www.w3.org/2001/XMLSchema#string

P407

P478

2012

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2012-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

230593270

http://www.w3.org/2001/XMLSchema#string

P698

22851965

http://www.w3.org/2001/XMLSchema#string

P921

regulation of gene expression

physiological phenomena

P932

3407629

http://www.w3.org/2001/XMLSchema#string